Staphylococcus aureus, MRSA
| TEST NAME |
Staphylococcus aureus (MRSA) |
| DISEASE/DISORDER |
Bacteremia, pneumonia, surgical site infections, skin infections |
| ALTERNATE NAME(S) |
S.aureus, Staph aureus, Methicillin-resistant Staphylococcus aureus, MRSA |
| METHODOLOGY |
Culture |
| SPECIAL INSTRUCTIONS |
CEDEP approval required prior to isolate submission.
|
| ORDERING INFORMATION |
TDH DLS Requisition: PH-4182 Clinical Submission Requisition |
Patient Preparation
|
|
| Specimen Collection |
|
| Specimen Labeling |
- Specimen must be labeled with at least two unique patient identifiers and match accompanying PH-4182 Clinical Submission Requisition.
|
| Specimen Processing |
|
| Specimen Storage and Preservation |
- Isolates should be stored at ambient conditions.
|
| Specimen Transport |
- Ship isolates in ambient conditions.
- Do not send isolates refrigerated or frozen,
- All infectious substance shipments must conform to U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR 49 C.F.R. Parts 171-180).
|
| Specimen Acceptability and Rejection |
- Specimens that do not adhere to all specimen requirements will be rejected.
|
| Testing Location |
|
This Page Last Updated: September 15, 2025 at 1:22 PM